Table 2.
Hemodynamics parameters and biological investigations during TTE exam
| Hemodynamic | |||
| HR, bpm | 82 [71–90] | 78 [59–103] | 0.66 |
| SAP, mmHg | 128 [115–138] | 120 [110–131] | 0.11 |
| DAP, mmHg | 65 [59–73] | 62 [53–71] | 0.27 |
| MAP, mmHg | 86 [76–94] | 85 [71–91] | 0.46 |
| SpO2, % | 93 [91–96] | 93 [91–96] | 0.74 |
| T, °Celcius | 37.6 [36.7–38.3] | 36.8 [36.4–37.7] | 0.07 |
| SOFA score during TTE | 3 [2–5] | 5 [3–10] | 0.002 |
| SOFA cardiovascular score during TTE | 0 [0–1] | 4 [1–4] | 0.0001 |
| Critical group (n = 25) | |||
| Norepinephrine use, n (%) | 14 (22) | 11 (69) | < 0.001 |
| Norepinephrine (ug/Kg/min) | 0.26 [0.12–0.96] | 0.15 [0.12–0.28] | 0.56 |
| Mechanical ventilation, n (%) | 25 (41) | 13 (81) | 0.005 |
| PEEP (cmH 2 O) | 10 [7–12] | 11 [9–14] | 0.73 |
| PaO2, mmHg | 79 [65–98] | 87 [68–120] | 0.96 |
| Biological investigations | |||
| WBC, mm−3 | 9000 [6100–12900] | 7300 [5850–13525] | 0.47 |
| Lymphocyte count, mm−3 | 700 [400–1250] | 800 [300–1100] | 0.84 |
| Hemoglobin, g l−1 | 12.6 [11.1–13.4] | 12.0 [11.4–13.6] | 0.90 |
| C reactive protein, mg l−1 | 132 [97–220] | 152 [144–195] | 0.52 |
| Creatinin, umol l−1 | 71 [58–90] | 82 [56–154] | 0.23 |
| Troponine Tc HS, ng ml−1 | 18 [6–42] | 48.5 [3.25–148] | 0.48 |
| BNP, pg ml−1 | 66 [42–123] | 119 [40–185] | 0.42 |
Bold indicates P < 0.05
Continuous variables are expressed as median [interquartile range]
BNP brain natriuretic peptide, COPD chronic obstructive pulmonary disease, DAP diastolic arterial pressure, HR heart rate, MAP mean arterial pressure, PEEP positive end-expiratory pressure, SAP systolic arterial pressure, SOFA sequential organ failure assessment, Sp02 pulse saturation of oxygen, TTE transthoracic echocardiography, WBC white blood cell